ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,846.00
      0.00%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.70
      -0.76%
      Bitcoin
      62,999.64
      -2.86%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. IDEAYA Biosciences Inc (IDYA)

      7. IDEAYA Biosciences Inc (IDYA) News

      IDYA

      IDEAYA Biosciences (IDYA)

      IDEAYA Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDYA
      DateTimeSourceHeadlineSymbolCompany
      12/15/20237:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      12/14/20237:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      12/11/20235:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      12/08/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
      12/05/20236:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Upcoming December 2023 Investor Relations EventNASDAQ:IDYAIDEAYA Biosciences Inc
      12/04/20235:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      12/04/20236:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      12/04/20236:00AMPR Newswire (US)IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder CancerNASDAQ:IDYAIDEAYA Biosciences Inc
      12/03/20239:00AMPR Newswire (US)IDEAYA Announces Agenda for Investor R&D Day Webcast on December 4, 2023NASDAQ:IDYAIDEAYA Biosciences Inc
      11/28/20235:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      11/27/20235:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      11/17/20236:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      11/07/20235:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      11/07/20234:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IDYAIDEAYA Biosciences Inc
      11/07/20236:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      11/07/20236:00AMPR Newswire (US)IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
      11/01/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Plans for Investor R&D Day and Participation in Jefferies London Healthcare ConferenceNASDAQ:IDYAIDEAYA Biosciences Inc
      10/27/20234:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      10/27/20234:02PMPR Newswire (US)IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:IDYAIDEAYA Biosciences Inc
      10/27/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
      10/25/20239:45PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IDYAIDEAYA Biosciences Inc
      10/24/202310:15PMPR Newswire (US)IDEAYA Announces Pricing of Public OfferingNASDAQ:IDYAIDEAYA Biosciences Inc
      10/24/20235:26PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IDYAIDEAYA Biosciences Inc
      10/24/20234:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      10/24/20234:07PMPR Newswire (US)IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:IDYAIDEAYA Biosciences Inc
      10/23/20238:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      10/23/20236:00AMPR Newswire (US)IDEAYA Announces Top-Line Phase 2 Results at ESMO 2023 of Darovasertib and Crizotinib Combo in MUM, and Clinical Efficacy Updates for Neoadjuvant UM, GNAQ/11 Cutaneous Melanoma, and Synthetic Lethality PipelineNASDAQ:IDYAIDEAYA Biosciences Inc
      10/17/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2023 for Phase 2 Clinical Data Update for Darovasertib and Crizotinib Combination in Metastatic Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      10/16/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Phase 2 Expansion of Darovasertib and Crizotinib Combination in GNAQ/11 Metastatic Cutaneous MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      10/09/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Development Candidate Nomination of a Werner Helicase Inhibitor in Collaboration with GSK and Investor R&D DayNASDAQ:IDYAIDEAYA Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:IDYA